Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
NCT02349009
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Scleroderma
Interventions
DRUG:
C-82 Topical Gel, 1%
DRUG:
C-82 Topical Gel, Placebo
Sponsor
Prism Pharma Co., Ltd.